Targeting Dysregulation in Metabolic Diseases: Potential Therapeutic Intervention

Metabolic diseases, such as diabetes, obesity, and metabolic syndrome, have become increasingly prevalent worldwide, primarily due to sedentary lifestyles and poor dietary choices. These diseases are characterized by dysregulated metabolic processes, leading to severe health implications. Despite advancements in research and treatment, understanding and managing these complex diseases remain a significant challenge. Current studies reveal that metabolic dysregulation plays a central role in the pathogenesis of these conditions. Ongoing research centers around identifying key molecular targets and effective therapeutic interventions. While several pharmacological treatments exist, their efficacy and potential side effects warrant further investigation to refine therapeutic approaches and develop novel, more effective treatments.

This research topic aims to explore the pharmacological possibilities for therapeutic intervention in metabolic diseases by targeting dysregulated metabolic pathways. The primary objectives include identifying new molecular targets, evaluating the effectiveness of existing treatments, and developing novel compounds or drug delivery systems to enhance treatment efficacy and safety. Specifically, the research will focus on understanding the underlying mechanisms of metabolic dysregulation and assessing innovative pharmacological strategies to improve patient outcomes.

To gather further insights into the pharmacological possibilities for therapeutic intervention in metabolic diseases, we welcome articles addressing, but not limited to, the following themes:

- Evaluation of existing pharmacological treatments and their mechanisms.
- Development of new drug candidates and delivery systems for metabolic diseases.
- Assessing the safety and efficacy of pharmacological interventions through clinical trials.

We encourage a range of article types including original research articles, reviews, and case studies to contribute to this evolving field.

Keywords: metabolic disease, metabolic syndrome, dysregulation, key molecular targets, therapeutic interventions, drug delivery systems

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.